Pseudopapillomata of the vesical and/or urethral mucosa were found in 195 patients among a total of 2046 patients at a Spinal Cord Injury Center. Of these, 169 cases were studied, and an incidence of 7.9% vesical and 1.6% urethral pseudopapillomatosis was found. Neither the age nor the level of the cord lesion seemed to play a significant role. Most pseudopapillomata were diagnosed in the first year after injury. Patients with catheters and pseudopapillomata outnumbered those without catheters 3 to 1. The role of infection and a high incidence of vesical and renal calculosis was demonstrated. Location of the bladder lesion seemed to favor the points of contact with the Foley bag. Therefore, it would be logical to replace Foley bag catheter drainage by whistle tip catheter drainage in spinal cord injury patients. Histological findings were described. The present policy of therapy at this Center was outlined. Recurrences were more frequent in the bladder than in the urethra. Electrofulguration appeared to be an effective modality of therapy. Biopsies are recommended because of potential, but rare, malignant degeneration.

This content is only available via PDF.
© 1966 S. Karger AG, Basel
1966
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.